Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | TLR4 | O00206 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14895102 | 0.98 | KMT2A (0.48) | MCL1CA1CA2CA4KMT2A | |
| SCHEMBL14895365 | 0.98 | KMT2A (0.48) | MCL1CA1CA2CA4KMT2A | |
| SCHEMBL14895507 | 0.98 | KMT2A (0.48) | MCL1CA1CA2CA4KMT2A | |
| SCHEMBL14895250 | 0.98 | KMT2A (0.48) | MCL1CA1CA2CA4KMT2A | |
| SCHEMBL6353877 | 0.93 | — | — | |
| SCHEMBL7981400 | 0.82 | CA1 (0.50) | MCL1CA1CA2CA4KMT2A | |
| SCHEMBL63339 | 0.80 | MCL1 (0.53) | MCL1CA1CA2CA4KMT2A | |
| SCHEMBL11664151 | 0.78 | MCL1 (0.52) | MCL1CA1CA2CA4KMT2A | |
| SCHEMBL6914585 | 0.78 | MCL1 (0.52) | MCL1CA1CA2CA4KMT2A | |
| SCHEMBL15364870 | 0.78 | MCL1 (0.52) | MCL1CA1CA2CA4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118103345-A | Method for producing compound comprising isomerization step of alpha, beta-unsaturated ketone | 花王株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-115943229-A | Cyclic compounds as aromachemicals | 巴斯夫欧洲公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-114853585-A | Heterogeneous catalysis double bond isomerization method | 江苏宏邦化工科技有限公司 | 2022-08-05 | — | — | CN | disclosed |
| US-10626099-B2 | Process for preparing pleuromutilin | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2020-04-21 | — | — | US | disclosed |
| WO-2019075195-A1 | PROCESSES FOR PREPARING PLEUROMUTILIN | FARNEY ELLIOT P (US) | 2019-04-18 | — | — | WO | disclosed |
| US-20190106400-A1 | Process For Preparing Pleuromutilin | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2019-04-11 | — | — | US | disclosed |
| US-9371262-B2 | One-step intermolecular electrocyclic rearrangement process | GIVAUDAN S.A. (CH) | 2016-06-21 | — | — | US | disclosed |
| US-20140288326-A1 | NOVEL PROCESS | GIVAUDAN S.A. (CH) | 2014-09-25 | — | — | US | disclosed |
| EP-2771331-A1 | NOVEL PROCESS | Givaudan SA (CH) | 2014-09-03 | — | — | EP | disclosed |
| WO-2013060011-A1 | NOVEL PROCESS | GIVAUDAN SA (CH) | 2013-05-02 | — | — | WO | disclosed |
| WO-2013060818-A1 | NOVEL PROCESS | GIVAUDAN SA (CH) | 2013-05-02 | — | — | WO | disclosed |
| US-6974658-B2 | HIGH MOLECULAR COMPOUND, MONOMER COMPOUNDS AND PHOTOSENSITIVE COMPOSITION FOR PHOTORESIST, PATTERN FORMING METHOD UTILIZING PHOTOSENSITIVE COMPOSITION, AND METHOD OF MANUFACTURING ELECTRONIC COMPONENTS | KABUSHIKI KAISHA TOSHIBA (JP) | 2005-12-13 | — | — | US | disclosed |
| US-20030235781-A1 | High molecular compound, monomer compounds and photosensitive composition for photoresist, pattern forming method utilizing photosensitive composition, and method of manufacturing electronic components | KABUSHIKI KAISHA TOSHIBA (JP) | 2003-12-25 | — | — | US | disclosed |
| EP-0162572-B1 | SILOXANE POLYPHOTOINITIATORS OF THE SUBSTITUTED ACETOPHENONE TYPE | LOCTITE CORPORATION (US) | 1989-01-25 | — | — | EP | disclosed |
| US-4534838-A | Siloxane polyphotoinitiators of the substituted acetophenone type | LOCTITE CORPORATION (US) | 1985-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190106400-A1 | Process For Preparing Pleuromutilin | PLEC, MLN, MRPL21 | MCL1 4624/4885CA1 2282/4885CA2 3818/4885 |
| US-10626099-B2 | Process for preparing pleuromutilin | PLEC, MLN, MRPL21 | MCL1 4624/4885CA1 2282/4885CA2 3818/4885 |
| US-20140288326-A1 | NOVEL PROCESS | COASY, ADH1C, AKR1C2 | MCL1 2649/4885CA1 1681/4885CA2 3419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.